{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:14:39Z","timestamp":1789600479326,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,27]]},"DOI":"10.7759\/cureus.67974","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T04:33:42Z","timestamp":1724819622000},"source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of Lipid Profile Modulation by Berberis asiatica, Withania somnifera, and Their Synergy in Type 2 Diabetic Wistar Rats"],"prefix":"10.7759","author":[{"given":"Devkumar D","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana M","family":"Thorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathamesh V","family":"Pakale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanashri","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Essentials of Medical Pharmacology","author":"Tripathi KD","year":"2019","unstructured":"Tripathi KD. Essentials of Medical Pharmacology. Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India; 2019."},{"key":"ref2","article-title":"Type 2 diabetes","author":"Goyal R","year":"2023","unstructured":"Goyal R, Singhal M, Jialal I. Type 2 diabetes. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/11795514231220780","article-title":"Cardiometabolic risk factors associated with type 2 diabetes mellitus: a mechanistic insight","volume":"16","author":"Chakraborty S","year":"2023","unstructured":"Chakraborty S, Verma A, Garg R, Singh J, Verma H. Cardiometabolic risk factors associated with type 2 diabetes mellitus: a mechanistic insight. Clin Med Insights Endocrinol Diabetes. 2023, 16:10.1177\/11795514231220780","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-016-0167-x","article-title":"Diabetes dyslipidemia","volume":"7","author":"Schofield JD","year":"2016","unstructured":"Schofield JD, Liu Y, Rao-Balakrishna P, Malik RA, Soran H. Diabetes dyslipidemia. Diabetes Ther. 2016, 7:203-19. 10.1007\/s13300-016-0167-x","journal-title":"Diabetes Ther"},{"key":"ref5","article-title":"Dyslipidemia in patients with diabetes","author":"Feingold KR","year":"2023","unstructured":"Feingold KR. Dyslipidemia in patients with diabetes. Endotext [Internet]. Mdtext.com, Inc., South Dartmouth (MA); 2023."},{"key":"ref6","article-title":"Lipid management in patients with type 2 diabetes","volume":"4","author":"Daniel MJ","year":"2011","unstructured":"Daniel MJ. Lipid management in patients with type 2 diabetes. Am Health Drug Benefits. 2011, 4:312-22.","journal-title":"Am Health Drug Benefits"},{"key":"ref7","unstructured":"The Calgary guide to understanding disease. (2024). Accessed. August 5, 2024: https:\/\/calgaryguide.ucalgary.ca\/content\/."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00041","article-title":"Phytopharmacology and clinical updates of Berberis species against diabetes and other metabolic diseases","volume":"11","author":"Belwal T","year":"2020","unstructured":"Belwal T, Bisht A, Devkota HP, et al.. Phytopharmacology and clinical updates of Berberis species against diabetes and other metabolic diseases. Front Pharmacol. 2020, 11:41. 10.3389\/fphar.2020.00041","journal-title":"Front Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7324\/JABB.2024.167591","article-title":"The medicinal plant berberis aristata and its endophytes for pharmacological applications: current research and future challenges","volume":"12","author":"Sharma S","year":"2024","unstructured":"Sharma S, Chaitanya MVNL, Sharma S, et al.. The medicinal plant berberis aristata and its endophytes for pharmacological applications: current research and future challenges. J Appl Biol Biotech. 2024, 12:37-46. 10.7324\/JABB.2024.167591","journal-title":"J Appl Biol Biotech"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S205319","article-title":"Antidiabetic activity enhancement in streptozotocin + nicotinamide-induced diabetic rats through combinational polymeric nanoformulation","volume":"14","author":"Rani R","year":"2019","unstructured":"Rani R, Dahiya S, Dhingra D, Dilbaghi N, Kaushik A, Kim KH, Kumar S. Antidiabetic activity enhancement in streptozotocin + nicotinamide-induced diabetic rats through combinational polymeric nanoformulation. Int J Nanomedicine. 2019, 14:4383-95. 10.2147\/IJN.S205319","journal-title":"Int J Nanomedicine"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.40.163","article-title":"Indian herbs and herbal drugs used for the treatment of diabetes","volume":"40","author":"Modak M","year":"2007","unstructured":"Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TP. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr. 2007, 40:163-73. 10.3164\/jcbn.40.163","journal-title":"J Clin Biochem Nutr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24109085","article-title":"The management of diabetes mellitus using medicinal plants and vitamins","volume":"24","author":"Yedjou CG","year":"2023","unstructured":"Yedjou CG, Grigsby J, Mbemi A, Nelson D, Mildort B, Latinwo L, Tchounwou PB. The management of diabetes mellitus using medicinal plants and vitamins. Int J Mol Sci. 2023, 24:9085. 10.3390\/ijms24109085","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/biom9100551","article-title":"Antidiabetic potential of medicinal plants and their active components","volume":"9","author":"Salehi B","year":"2019","unstructured":"Salehi B, Ata A, V Anil Kumar N, et al.. Antidiabetic potential of medicinal plants and their active components. Biomolecules. 2019, 9:551. 10.3390\/biom9100551","journal-title":"Biomolecules"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.15584\/ejcem.2018.1.7","article-title":"Fundamentals of the use of Berberis as a medicinal plant","volume":"16","author":"Bober Z","year":"2018","unstructured":"Bober Z, St\u0119pie\u0144 A, Aebisher D, O\u017c\u00f3g \u0141, Bartusik-Aebisher D. Fundamentals of the use of Berberis as a medicinal plant. Eur J Clin Exp Med. 2018, 16:41-6. 10.15584\/ejcem.2018.1.7","journal-title":"Eur J Clin Exp Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.23812\/j.biol.regul.homeost.agents.20233710.494","article-title":"The role of ashwagandha in metabolic syndrome: a review of traditional knowledge and recent research findings","volume":"37","author":"Rakha A","year":"2023","unstructured":"Rakha A, Ramzan J, Umar N, et al.. The role of ashwagandha in metabolic syndrome: a review of traditional knowledge and recent research findings. J Biol Regul Homeost Agents. 2023, 37: 5091-103. 10.23812\/j.biol.regul.homeost.agents.20233710.494","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00201","article-title":"Synergistic effects of Chinese herbal medicine: a comprehensive review of methodology and current research","volume":"7","author":"Zhou X","year":"2016","unstructured":"Zhou X, Seto SW, Chang D, Kiat H, Razmovski-Naumovski V, Chan K, Bensoussan A. Synergistic effects of Chinese herbal medicine: a comprehensive review of methodology and current research. Front Pharmacol. 2016, 7:201. 10.3389\/fphar.2016.00201","journal-title":"Front Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.64379","article-title":"Study of antidiabetic properties of Berberis asiatica and Withania somnifera in streptozotocin-nicotinamide-induced type ii diabetes mellitus in Wistar rats","volume":"16","author":"Tiwari DD","year":"2024","unstructured":"Tiwari DD, Thorat VM, Pakale PV, Patil SJ. Study of antidiabetic properties of Berberis asiatica and Withania somnifera in streptozotocin-nicotinamide-induced type ii diabetes mellitus in Wistar rats. Cureus. 2024, 16:e64379. 10.7759\/cureus.64379","journal-title":"Cureus"},{"key":"ref18","unstructured":"Test no. 240. Medaka extended one generation reproduction test (MEOGRT). (2023). Accessed: August 5, 2024: https:\/\/doi.org\/10.1787\/9789264242258-en.."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120232","article-title":"Arjunolic acid downregulates elevated blood sugar and pro-inflammatory cytokines in streptozotocin (STZ)-nicotinamide induced type 2 diabetic rats","volume":"289","author":"Aamir K","year":"2022","unstructured":"Aamir K, Khan HU, Hossain CF, et al.. Arjunolic acid downregulates elevated blood sugar and pro-inflammatory cytokines in streptozotocin (STZ)-nicotinamide induced type 2 diabetic rats. Life Sci. 2022, 289:120232. 10.1016\/j.lfs.2021.120232","journal-title":"Life Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1139\/bcb-2014-0107","article-title":"Berberine as a therapy for type 2 diabetes and its complications: from mechanism of action to clinical studies","volume":"93","author":"Chang W","year":"2015","unstructured":"Chang W, Chen L, Hatch GM. Berberine as a therapy for type 2 diabetes and its complications: from mechanism of action to clinical studies. Biochem Cell Biol. 2015, 93:479-86. 10.1139\/bcb-2014-0107","journal-title":"Biochem Cell Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia","volume":"5","author":"Sampson M","year":"2020","unstructured":"Sampson M, Ling C, Sun Q, et al.. A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia. JAMA Cardiol. 2020, 5:540-8. 10.1001\/jamacardio.2020.0013","journal-title":"JAMA Cardiol"},{"key":"ref22","article-title":"The wisdom of prevention: holistic, preventive herb approach for healing of the globe","volume":"10","author":"Rana P","year":"2021","unstructured":"Rana P, Kumar A, Choudhary A, Kaur H, Singh R. The wisdom of prevention: holistic, preventive herb approach for healing of the globe. J Pharm Innov. 2021, 10:29-46.","journal-title":"J Pharm Innov"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong W","year":"2004","unstructured":"Kong W, Wei J, Abidi P, et al.. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004, 10:1344-51. 10.1038\/nm1135","journal-title":"Nat Med"},{"key":"ref24","unstructured":"The prevention of cruelty to animal act, 1960. (2024). Accessed. August 5, 2024: https:\/\/ccsea.gov.in\/Content\/54_1_ACTS,RULESANDGUIDELINES.aspx."},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.2174\/0929867323666160411143314","article-title":"Berberine: new insights from pharmacological aspects to clinical evidences in the management of metabolic disorders","volume":"23","author":"Caliceti C","year":"2016","unstructured":"Caliceti C, Franco P, Spinozzi S, Roda A, Cicero FGA. Berberine: new insights from pharmacological aspects to clinical evidences in the management of metabolic disorders. Curr Med Chem. 2016, 23:1460-76.","journal-title":"Curr Med Chem"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24338","article-title":"Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance","volume":"10","author":"Li L","year":"2024","unstructured":"Li L, Xiao Y, Zhou J, et al.. Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance. Heliyon. 2024, 10:e24338. 10.1016\/j.heliyon.2024.e24338","journal-title":"Heliyon"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0006","article-title":"Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states","volume":"55","author":"Lee YS","year":"2006","unstructured":"Lee YS, Kim WS, Kim KH, et al.. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006, 55:2256-64. 10.2337\/db06-0006","journal-title":"Diabetes"},{"key":"ref28","article-title":"Practical Pharmacognosy Techniques and Experiments","author":"Khandelwal KR","year":"2008","unstructured":"Khandelwal KR. Practical Pharmacognosy Techniques and Experiments. Khandelwal KR  (ed): Nirali Books Pvt. Ltd, Pune, India; 2008."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.53365\/nrfhh\/177661","article-title":"Therapeutic effect of Withania somnifera (ashwagandha) on depression: a comprehensive review","volume":"4","author":"Ibrahim M","year":"2024","unstructured":"Ibrahim M, Pawar G, Khan N, Gudalwar B, Khan S, Mazhar M. Therapeutic effect of Withania somnifera (ashwagandha) on depression: a comprehensive review. NRFHH. 2024, 4:142-51. 10.53365\/nrfhh\/177661","journal-title":"NRFHH"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041057","article-title":"Ashwagandha (Withania somnifera)\u2014current research on the health-promoting activities: a narrative review","volume":"15","author":"Mikulska P","year":"2023","unstructured":"Mikulska P, Malinowska M, Ignacyk M, et al.. Ashwagandha (Withania somnifera)\u2014current research on the health-promoting activities: a narrative review. Pharmaceutics. 2023, 15:1057. 10.3390\/pharmaceutics15041057","journal-title":"Pharmaceutics"},{"key":"ref31","article-title":"Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review","volume":"5","author":"Mishra LC","year":"2019","unstructured":"Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Altern Med Rev. 2019, 5:334-46.","journal-title":"Altern Med Rev"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms10052367","article-title":"Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic rats","volume":"10","author":"Udayakumar R","year":"2009","unstructured":"Udayakumar R, Kasthurirengan S, Mariashibu TS, et al.. Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic rats. Int J Mol Sci. 2009, 10:2367-82. 10.3390\/ijms10052367","journal-title":"Int J Mol Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1049334","article-title":"An updated review on phytochemistry and molecular targets of Withania somnifera (L.) Dunal (Ashwagandha)","volume":"14","author":"Bashir A","year":"2023","unstructured":"Bashir A, Nabi M, Tabassum N, Afzal S, Ayoub M. An updated review on phytochemistry and molecular targets of Withania somnifera (L.) Dunal (Ashwagandha). Front Pharmacol. 2023, 14:1049334. 10.3389\/fphar.2023.1049334","journal-title":"Front Pharmacol"},{"key":"ref34","article-title":"Natural sources as potential anti-cancer agents: a review","volume":"3","author":"Bhanot A","year":"2011","unstructured":"Bhanot A, Sharma R, and Noolvi MN. Natural sources as potential anti-cancer agents: a review. Phytomedicine. 2011, 3:9-26.","journal-title":"Phytomedicine"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-8741(02)00034-x","article-title":"Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property","volume":"81","author":"Sabu MC","year":"2002","unstructured":"Sabu MC, Kuttan R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002, 81:155-60. 10.1016\/s0378-8741(02)00034-x","journal-title":"J Ethnopharmacol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.IJP_217_18","article-title":"Effect of a polyherbal formulation in streptozotocin-induced diabetic nephropathy in Wistar rats","volume":"51","author":"Reddy KS","year":"2019","unstructured":"Reddy KS, Sudheer A, Pradeepkumar B, Reddy CS. Effect of a polyherbal formulation in streptozotocin-induced diabetic nephropathy in Wistar rats. Indian J Pharmacol. 2019, 51:330-6. 10.4103\/ijp.IJP_217_18","journal-title":"Indian J Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.4103\/2231-4040.111527","article-title":"Development of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle system","volume":"4","author":"Gauttam VK","year":"2013","unstructured":"Gauttam VK, Kalia AN. Development of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle system. J Adv Pharm Technol Res. 2013, 4:108-17. 10.4103\/2231-4040.111527","journal-title":"J Adv Pharm Technol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/285669-evaluation-of-lipid-profile-modulation-by-berberis-asiatica-withania-somnifera-and-their-synergy-in-type-2-diabetic-wistar-rats","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T04:33:54Z","timestamp":1724819634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/285669-evaluation-of-lipid-profile-modulation-by-berberis-asiatica-withania-somnifera-and-their-synergy-in-type-2-diabetic-wistar-rats"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.67974","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,27]]}}}